Toggle navigation
Home
Search
Services
Blog
Contact
About
SIRT1 and BCL6: Dual Biomarkers of Endometriosis and Endometrial Receptivity
Angress, Dan
Cicerodx, Inc., Huntington Beach, CA, United States
Search grants from Dan Angress
Search grants from Cicerodx, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
LFA-1 in lymphocyte migration
Strengthening Public Health Laboratory Systems in the Republic of Kenya Under the
Stem Cell Therapy
Structure, Process and Outcomes in the Pace Program
Metabolism of Extracellular Matrix in Injured Corneas
Recently added grants:
Role of hepatic IkBb-mediated sustained NFkB activation in neonatal lung injury and abnormal development
Dysregulated Nfkb Pathway Signaling in Myeloproliferative Neoplasms
Enhancement of Cardiac Cell therapy by reintroduction of developmental signaling
Systematic Investigation of Protein Ubiquitination in ARDS
The Effects of Older Red Cell Units in Adults with Sickle Cell Disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
4R44HD097750-02
Application #
10028286
Study Section
Special Emphasis Panel (ZHD1)
Program Officer
Tingen, Candace M
Project Start
2020-02-11
Project End
2022-01-31
Budget Start
2020-02-11
Budget End
2021-01-31
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Institution
Name
Cicerodx, Inc.
Department
Type
DUNS #
081007068
City
Huntington Beach
State
CA
Country
United States
Zip Code
92649
Related projects
NIH 2020
R44 HD
SIRT1 and BCL6: Dual Biomarkers of Endometriosis and Endometrial Receptivity
Angress, Dan / Cicerodx, Inc.
NIH 2019
R44 HD
SIRT1 and BCL6: Dual Biomarkers of Endometriosis and Endometrial Receptivity
Angress, Dan / Cicerodx, Inc.
Comments
Be the first to comment on Dan Angress's grant